LONDON, July 3, 2026, 19:04 BST
- Cirata (LON:CRTA) closed at 17.90p, gaining 6.9%. Volume hit 54,812 shares.
- The price is now 19.3% over the 15p fundraising level, but the new shares will make up 28.7% of the current share base.
- Investors will vote July 24, and the stock is set to start trading July 28.
Cirata Plc (LON:CRTA) climbed on Friday. The AIM-listed software stock, which sees light trading, jumped back above the level of its upcoming cash call. Cirata plans to test the market in July with 36.3 million new shares.
Shares closed at 17.90p, adding 1.15p, or 6.87%. The last print was at 16:35:20. The stock traded between 16.80p and 17.95p on the day. Volume came in at 54,812 shares.
| Friday tape | Cirata |
|---|---|
| Last price | 17.90p |
| Change | up 1.15p |
| Change % | up 6.87% |
| Open | 16.80p |
| High-low | 17.95p to 16.80p |
| Shares traded | 54,812 |
That’s what day-traders see. For investors, it’s the difference between Friday’s close and the 15p issue price. At 17.90p, those 36,310,971 new shares would be valued at around £6.5 million, versus the £5.4 million in gross cash coming in from the placing.
| Pending share issue | Number |
|---|---|
| Issue price | 15.0p |
| New shares to be issued | 36,310,971 |
| Gross proceeds | About £5.4 mln |
| New shares as % of existing shares | 28.7% |
| Value of new shares at 17.90p | About £6.5 mln |
| Friday volume as % of new shares | 0.15% |
Low volume is a factor. Only 0.15% of the stock set for admission this month changed hands on Friday, making the price move a weak signal for what the bigger equity might fetch.
Cirata’s newest RNS on Investegate was still the June 29 circular with the retail-offer result, with nothing newer filed. The circular called a general meeting for 11:00 a.m. on July 24 and gave the enlarged share capital as 162,759,626 shares after admission.
Cirata raised £5.1 million after its oversubscribed placing and subscription, as announced on June 26. The company issued 34,155,349 new shares at 15p. Cirata added another £0.32 million from the retail offer, selling 2,155,622 more shares.
Cirata is “a transformed business,” Chief Executive Stephen Kelly said in the fundraising statement. Kelly also called FY25 the company’s “first triple-digit sales growth year.” He said about 43% of the pipeline over the next four quarters is co-sourced with International Business Machines Corp NYSE:IBM. Investegate
The IBM deal is key to Cirata’s turnaround story. Cirata announced in June that IBM would sell Cirata Symphony to clients as Cirata Symphony for IBM Big Replicate. CEO Kelly called it “The age of live data.” Investegate
FTSE Russell said in a July 2 report that Cirata was down 6.9% for the year before Friday’s move. That put it 12.1 points up on its FTSE UK All-Share sector, but 13.0 points behind the FTSE UK All-Share index.
| FTSE Russell data to July 2 | Cirata absolute | Relative to sector | Relative to FTSE UK All-Share |
|---|---|---|---|
| 1 day | -1.3% | -1.0 pts | -2.8 pts |
| Week to date | -0.4% | -1.6 pts | -1.8 pts |
| Month to date | -1.5% | -2.3 pts | -2.9 pts |
| Year to date | -6.9% | +12.1 pts | -13.0 pts |
FTSE Russell data shows Cirata trading at a trailing price-to-sales ratio of 2.5, below the sector median of 3.3 for software and computer services. Price-to-book came in at 3.0. Cirata’s trailing PE, EV/EBITDA and price-to-cash-flow were all still negative.
